Antizyme inhibitor (AzI) is a homolog of ornithine decarboxylase (ODC), a key enzyme of polyamine synthesis. Antizyme inhibitor retains no enzymatic activity, but exhibits high affinity to antizyme (Az), a negative regulator of polyamine homeostasis. As polyamines are involved in maintaining cellular proliferation, and since AzI may negate Az functions, we have investigated the role of AzI in regulating cell growth. We show here that overexpression of AzI in NIH3T3 cells increased growth rate, enabled growth in low serum, and permitted anchorage-independent growth in soft agar, while reduction of AzI levels by AzI siRNA reduced cellular proliferation. Moreover, AzI overproducing cells gave rise to tumors when injected into nude mice. AzI overexpression resulted in elevation of ODC activity and of polyamine uptake. These effects of AzI are a result of its ability to neutralize Az, as overexpression of an AzI mutant with reduced Az binding failed to alter cellular polyamine metabolism and growth properties. We also demonstrate upregulation of AzI in Ras transformed cells, suggesting its relevance to some naturally occurring transformations. Finally, increased uptake activity rendered AzI overproducing and Ras-transformed cells more sensitive to toxic polyamine analogs. Our results therefore imply that AzI has a central and meaningful role in modulation of polyamine homeostasis, and in regulating cellular proliferation and transformation properties.
Introduction
Polyamines are small aliphatic cations that are found in all living cells and are essential for the process of cell growth (Tabor and Tabor, 1984; Pegg, 1988; Janne et al., 1991) . The association of increased polyamine levels with rapid cell proliferation and cancer is well established. Increased polyamine levels are associated with increased cell proliferation, decreased apoptosis and expression of genes affecting tumor invasion and metastasis (Gerner and Meyskens, 2004) . The first and rate limiting enzyme in the polyamine biosynthesis pathway is ornithine decarboxylase (ODC, EC 4.1.1.17) . Ornithine decarboxylase activity is induced during growth stimulation of quiescent cells (Kahana and Nathans, 1984) and is constitutively increased in cells transformed by oncogenes (Holtta et al., 1988; Sistonen et al., 1989; Holtta et al., 1993) , treated with carcinogens (Yuspa et al., 1976; Gilmour et al., 1985) , infected by viruses (Don and Bachrach, 1975; Gazdar et al., 1976; Haddox et al., 1980) , and in a variety of malignancies (Janne et al., 1983; Luk and Baylin, 1984; Pegg, 1988; Katz and Kahana, 1989; Tonin et al., 1989) . Inhibition of ODC activity interferes with cellular transformation induced by proto-oncogenes (Auvinen et al., 1992; Holtta et al., 1993) . In some cases, ODC overexpression is sufficient to induce cellular transformation (Auvinen et al., 1992; Moshier et al., 1993; Shantz and Pegg, 1994; Clifford et al., 1995) , and spontaneous skin tumors in nude mice (Megosh et al., 1995) . Recently, ODC was found to be an important downstream mediator of Myc-and APCdependent transformation pathways (Gerner and Meyskens, 2004; Nilsson et al., 2005) .
Ornithine decarboxylase is regulated by multiple control mechanisms, including transcription, translation, post-translational modifications, and rapid degradation. Ornithine decarboxylase is one of the most rapidly degraded mammalian proteins, and its degradation is regulated by polyamines via an ubiquitin independent mechanism. This is achieved by a unique mechanism in which a polyamine-induced protein termed antizyme (Az) binds and inactivates ODC, and subsequently targets it for rapid degradation by the 26S proteosome Rosenberg-Hasson et al., 1989; Murakami et al., 1992a) . In addition to its role in regulating ODC activity and degradation, antizyme was also demonstrated to regulate polyamine transport across the plasma membrane via a yet unknown mechanism Mitchell et al., 1994; Suzuki et al., 1994; Sakata et al., 2000) . In accordance with these observations, recent studies have established that Az may act as a tumor suppressor, as its induction is associated with growth inhibition (Mitchell et al., 2002) , while its overexpression increases apoptosis and reduces tumorigenesis (Feith et al., 2001; Fong et al., 2003) .
Mammalian cells contain yet another protein relevant to the regulation of ODC. This protein, termed antizyme inhibitor (AzI), was originally detected in rat liver extract due to its ability to reactivate ODC inhibited by Az (Fujita et al., 1982) . AzI displays profound homology to ODC, but lacks decarboxylation activity (Murakami et al., 1996; Nilsson et al., 2000) . The affinity of Az to AzI is higher than its affinity to ODC (Fujita et al., 1982; Kitani and Fujisawa, 1989; Murakami et al., 1989) . Therefore, AzI can rescue ODC from degradation (Murakami et al., 1989) . The ability of AzI to antagonize Az functions suggests that AzI may function as a regulator of cell growth and transformation. Human AzI gene is located on chromosome 8q22.3, and amplification of this region were found in several tumors (Schaner et al., 2005; van Duin et al., 2005) . In agreement with this hypothesis are recent findings demonstrating AzI overexpression in gastric tumors (Jung et al., 2000) , and decreased intracellular polyamine levels and reduced cell proliferation in cells with downregulated AzI expression (Choi et al., 2005) .
In the present study, we directly examined the effect of AzI overexpression on cell proliferation and transformation. We have demonstrated that overexpression of AzI in mouse NIH3T3 fibroblasts results in elevated polyamine levels, an increased growth rate and in the acquisition of a transformed phenotype. Our data suggest that the growth advantage brought by increased expression of AzI is a result of neutralization of Az functions leading to increased ODC activity and increased polyamine uptake. Our results demonstrate that increased expression of AzI can provoke cellular transformation, and suggest it as a potential target for cancer therapy.
Results
Overexpression of AzI provides growth advantage and causes cell transformation High levels of ODC activity and high cellular content of polyamines are hallmarks of cell transformation (Marton and Pegg, 1995) . As AzI directly inhibits Az and thereby upregulates ODC levels (Murakami et al., 1989) and, possibly, polyamine transport, we predicted that AzI might be an important regulator of cellular proliferation and transformation. To test this possibility, we have constructed an NIH3T3-derived cell line constitutively overexpressing AzI. For this purpose, mouse AzI cDNA was cloned into the pEFIRES-p bicistronic vector (Hobbs et al., 1998) , the resulting construct was transfected into NIH3T3 cells, and stable transformants were selected for their ability to grow in the presence of puromycin. NIH3T3 cells stably transfected with an empty pEFIRES-p vector served as a control (NIH3T3-E). In all the following experiments, stable polyclonal populations were assayed. Western blot analysis demonstrated increased levels of AzI in the NIH3T3-AzI cell. (Figure 1a, lane 2) . Antizyme inhibitor overproducing cells proliferated more rapidly than control cells (Figure 1b) , grew efficiently in medium containing only 0.5% serum (Figure 1c ) and formed colonies in soft agar (Figure 1d) . Conversely, expression of AzI-specific siRNA decreased ODC activity (data not shown) and reduced cell growth (Figure 1e ) (the observed 20% decrease in total cell number 24 h after transfection is actually more significant, as transfection efficiency was 50%). Furthermore, NIH3T3-AzI but not NIH3T3-E cells gave rise to tumors following their subcutaneous injection into nude mice. The subcutaneous masses were nodular and discrete, and varied in mass from 0.05 to 2.2 g. Microscopically the masses were well-demarcated, expansile and unencapsulated, and composed of densely cellular sheets and interlacing fascicles of spindle cells (Figure 2 ). Neoplastic cells were intermediate to large in size, had small to moderate amount of eosinophilic cytoplasm, clear cytoplasmic margins, oval, elongated, and irregular nuclei with moderately to finely granular chromatin and one or more magenta nucleoli. There was moderate anisocytosis and anisokaryosis (Figure 2 ). Mitotic figures averaged at approximately 3-5/highpower field ( Â 40). There was multifocal necrosis. The histologic diagnosis was sarcoma, consistent with fibrosarcoma.
Taken together, these results demonstrate that increased AzI expression as a single change in polyamine homeostasis may provide cells with significant growth advantage, leading to cellular transformation.
Overexpression of AzI results in increased polyamine levels, due to augmented ODC activity and elevated polyamine uptake It was previously demonstrated that overexpression of ODC in NIH3T3 cells leads to a transformed phenotype similar to that described here (Auvinen et al., 1992) . Antizyme has two distinct roles in polyamine homeostasis: it targets ODC for degradation Rosenberg-Hasson et al., 1989; Murakami et al., 1992b) and downregulates polyamine uptake Mitchell et al., 1994; Suzuki et al., 1994; Sakata et al., 2000) . Therefore, we expected that overexpression of AzI will affect polyamine homeostasis by influencing both processes. To test this hypothesis, we first set out to determine ODC activity in AzI and ODC overproducing cells and in control cells. A E20-fold increase in ODC activity was observed in NIH3T3-AzI cells, compared to a E40-fold increase measured in the ODC overexpressing cells ( Figure 3a) . Next, we measured uptake of spermidine in these three cell lines. While increased uptake of spermidine was observed in AzI overproducing cells, ODC overproducing cells displayed reduced uptake activity (Figure 3b ), probably due to increased translation of Az in the presence of high polyamine levels. The difference in ODC activity and polyamine uptake in AzI versus ODC overproducing cells may lead to a difference in their polyamine content. Indeed, while elevated levels of spermidine were noted in AzI and in ODC overproducing cells, the level of spermine was significantly higher in AzI overproducing cells ( Figure  3c and d). Dramatic increase in the concentration of putrescine was noted in ODC overproducing cells, while only slight increase of putrescine was evident in AzI overproducing cells (Figure 3c ). Interestingly, despite the difference in ODC activity AzI and ODC overproducing cells displayed similar growth rates ( Figure 3e ). Taken together, these results indicate that the increased concentration of polyamines in AzI overproducing cells is due to both augmented ODC activity and elevated polyamine uptake activities.
AzI regulation of polyamine levels depends on its ability to bind Az As demonstrated above, AzI overexpression increases ODC activity and polyamine uptake, two cellular processes regulated by Az. We, therefore, set out to directly test whether these two effects of AzI are caused by neutralization of Az functions. For this purpose, we constructed a cell line stably expressing an AzI mutant (MTM) that harbors nine point mutations in its Az binding segment thus displaying reduced Az binding (Bercovich and Kahana, 2004) (Figure 1a , lane 1). The growth rate of the resulting NIH3T3-AzI/MTM cells was similar to that of control NIH3T3-E cells (Figure 4a ). In agreement with this observation, NIH3T3-AzI/MTM cells displayed only slightly increased ODC and spermidine uptake activity ( Figure  4b and c). As ODC and polyamine uptake activity and the growth properties of these cells differ dramatically from those of cells overexpressing wild-type AzI, we conclude that the growth advantage and cellular transformation conferred by AzI results predominantly from inhibition of Az functions.
AzI is upregulated in Ras-transformed cells Next, we set out to determine whether the aboveproposed mechanism is relevant to known models of malignant transformation. In human cancers, Ras is one of the most commonly activated oncogenes. Structurally altered Ras proteins are detected in many types of tumors, enabling rapid cell growth in the absence of mitogenic signals (Bos, 1988; Khosravi-Far and Der, 1994) . Previous studies reported elevated ODC in Ras AzI stimulates cell proliferation and transformation A Keren-Paz et al transformed cells (Shantz and Pegg, 1998) . Ornithine decarboxylase activity measured in Ras-transformed NIH3T3 cells was comparable to that of NIH3T3-AzI cells (Figure 5a ). NIH3T3-Ras cells exhibited increased spermidine uptake activity that was similar to that observed in AzI-overproducing cells (Figure 5b) . Whereas the increased ODC activity in NIH3T3-Ras cells may result from direct upregulation of ODC (Shantz, 2004) , and from ODC stabilization by elevated AzI; the increased polyamine uptake activity is likely to result from upregulated AzI. To determine which of these players is elevated in the Ras transformed cells, we measured ODC, AzI, and Az mRNA levels in Ras, ODC, and AzI, overproducing cells and in control cells. While Az mRNA levels were similar in all the tested cell lines, AzI and ODC mRNA levels were significantly higher in Ras transformed cells compared to the control NIH3T3-E cells (Figure 5c ). Altogether, Ras transformed NIH3T3 cells displayed elevation of both ODC and AzI mRNAs, a situation similar to that observed in AzI overexpressing cells and different from that of ODC overproducing cells in which AzI mRNA was not elevated. We, therefore, propose that AzI participates in the Ras transformation pathway by mediating both ODC stabilization and polyamine uptake in naturally occurring tumors that harbor activated Ras.
AzI overproducing cells are more sensitive to a toxic polyamine analog than ODC overproducing cells The most profound difference between ODC and AzI overproducing cells was in their polyamine uptake activity, which was downregulated in ODC overproducing cells and upregulated in AzI overproducing cells. This difference may be of practical importance in determining the effectiveness of toxic polyamine analogs in cancer therapy, as they are expected to be more effective on AzI overproducing cells. To test this hypothesis, we utilized the polyamine analog CGC-11157, a cytotoxic cis-octamine that is readily taken up by cells and causes growth inhibition and cell death, presumably due to its ability to initiate DNA aggregation and thus alter DNA/chromatin condensation during cell cycle progression (Valasinas et al., 2003) . CGC-11157 was added to the growth medium of NIH3T3-E, NIH3T3-AzI and NIH3T3-ODC and their growth rate was compared. In agreement with their decrease polyamine uptake activity, ODC overexpressing cells grew more rapidly than control cells (Figure 6a ). In contrast, and in agreement with their increased polyamine uptake activity, AzI overexpressing cells were unable to grow in the presence of this analog ( Figure 6a) . Next, we have demonstrated that the growth inhibitory effect of CGC-11157 was significantly more profound on Ras-transformed cells than on control cells (Figure 6b) , further supporting the notion that Ras-transformed cells display increased polyamine uptake activity due to upregulated AzI. Figure 3 Characterization of ornithine decarboxylase (ODC) activity, polyamine uptake and polyamine content of antizyme inhibitor (AzI) overexpressing NIH3T3 cell line. (a) ODC activity assay was performed as described in Materials and methods. Quantification was performed using the Exbam program (Pixlock e.K). ODC activity was determined in extract prepared from NIH3T3-E (E), NIH3T3-AzI (AzI) and NIH3T3-ODC (ODC) cells. (b) Uptake of radioactive spermidine (0.5 and 5 mM) was determined as described in Materials and methods. The mean results of a triplicate measurement are shown. (c and d) Cellular extracts were prepared from NIH3T3-E (E), NIH3T3-AzI (AzI) and from NIH3T3-ODC (ODC) cells. Polyamines were subjected to dansylation reaction, fractionated as described in Materials and methods, and quantified by the Exbam program (Pixlock e.K). The location of markers representing putrescine (Put), spermidine (Spd) and spermine (Spm) is indicated. (e) Growth of NIH3T3-AzI (AzI), NIH3T3-ODC (ODC) and NIH3T3-E (E) cells in DMEM supplemented with 10% FBS. Cells were plated in 12-well plates, and counted at indicated times using a Bright Line Counting Chamber (Hausser Scientific). The mean number of cells from triplicate measurements is shown.
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Discussion
In this study, we report that overexpressing AzI in NIH3T3 cells leads to increased cell proliferation and induces cellular transformation. AzI overproduction in NIH3T3 cells increases growth rate in high and low serum, and permits anchorage-independent growth in soft agar. Antizyme inhibitor overexpression results in augmented ODC activity and increases polyamine uptake, thus leading to elevated cellular polyamine content. In agreement with a recent report (Choi et al., 2005) , we demonstrate that downregulation of AzI by compatible siRNA results in decreased cell proliferation. These effects of AzI are a result of its binding to Az and neutralizing its ability to target ODC for degradation (Li and Coffino, 1992; Murakami et al., 1992a, b; Mamroud-Kidron et al., 1994) and to inhibit polyamine uptake Mitchell et al., 1994; Suzuki et al., 1994; Sakata et al., 1997; Sakata et al., 2000) , as forced expression of an AzI mutant with reduced Az binding displays reduced effect on ODC activity, polyamine uptake or growth properties. As AzI affects cellular polyamine homeostasis by increasing both ODC activity and polyamine uptake, the regulation of polyamine levels in AzI overproducing cells is different than in ODC overproducing cells, in which the polyamines content is dependant solely on augmented ODC activity, as polyamine uptake is actually compromised (Figure 7) .
Although elevated ODC activity and high-polyamine content are characteristic of many tumors, the underlying mechanism is still rather unclear. It was shown that in some cases the increased ODC activity is a direct result of elevated ODC expression (Nilsson et al., 2005) . On the other hand, based on our present results and on a recent observation demonstrating increased levels of AzI mRNA in gastric tumors (Jung et al., 2000) , we propose here that augmented levels of ODC can be caused by its stabilization due to elevated AzI expression that neutralizes Az functions (Figure 7 ). More importantly, as we show here, overexpressed AzI also increases polyamine uptake, resulting in accumulation of spermidine and spermine. Elevation of AzI levels might be more efficient than direct overexpression of ODC in promoting rapid growth, since the latter does not provide a mechanism for neutralizing Az, whose expression is likely to be stimulated in cells upon increase in their polyamine levels. In accordance with this hypothesis, we were able to observe upregulation of AzI mRNA in Ras-transformed NIH3T3 cells. Ras is one of the best-characterized oncogenes, and it is activated in many naturally occurring tumors. We show here that Ras-transformed NIH3T3 cells have elevated levels of AzI and ODC mRNAs, increased ODC activity and augmented spermidine uptake. Therefore, it is likely that AzI is a downstream target of Ras, and might be important for malignant transformation of cells harboring mutant Ras. A strong correlation between high level of polyamines and rapid cellular proliferation placed the cellular polyamine metabolism in the focus of efforts for the development of antineoplastic therapy. This included the use of inhibitors of enzymes from the polyamine biosynthesis pathway and of polyamine analogs that are transported into cells by the polyamine transport system and interfere with polyamine functions. However, while Figure 7 Regulation of polyamine homeostasis by antizyme inhibitor (AzI) -suggested model. Antizyme is a central regulator of cellular polyamine levels, as it regulates both synthesis and uptake. We propose here that AzI regulates both functions of Az. An increase in the level of AzI results in trapping of Az through the formation of an inactive complex. This, in turn, leads to accumulation of ornithine decarboxylase (ODC) and increased uptake of polyamines. Therefore, the regulation of polyamine homeostasis in cells with high levels of AzI (dotted lines and arrows) is significantly different than that in cells with high levels of ODC (black lines and arrows). synthesis inhibitors such as a-difluoromethylornithine (a-DFMO, (Bey et al., 1978) ) are effective in inhibiting growth of cultured cells, they were rather disappointing in clinical trials, probably due to increased ability of tumor cells to transport polyamines from their environment (Moinard et al., 2005) . It should be noted that increased uptake of polyamines is incompatible with elevated ODC being the sole polyamine-related alteration in tumor cells, since increased ODC activity is expected to result in elevation of cellular polyamine levels, increased Az synthesis and decreased polyamine uptake. Conversely, since elevated AzI will neutralize Az, it will cause simultaneous increase in ODC and polyamine uptake activity. While tumors in which increased ODC is a primary event are expected to respond to treatment with biosynthesis inhibitors, tumors in which ODC increase is secondary to elevated AzI or is accompanied by increased AzI are expected to be refractory to biosynthesis inhibitors but responsive to treatment with toxic polyamine analogs. It will be therefore of interest and of therapeutic importance to determine the expression level of AzI and ODC in various naturally occurring tumors. Furthermore, inhibition of AzI expression or function may be of great therapeutic benefit when employed together with inhibitors of polyamine biosynthesis.
Materials and methods
Expression plasmids construction, cell lines and transfection
Mouse wild-type AzI, AzI/MTM mutant (described previously) (Bercovich and Kahana, 2004) and ODC cDNA were cloned between the XhoI and NotI sites of the bicistronic vector pEFIRES-p (Hobbs et al., 1998) . The resulting constructs and the empty vector (pEFIRES-E) were transfected into NIH3T3 mouse fibroblasts using jetPEI (Poly Transfection). Cells were selected for growth in the presence of puromycin, and a pool of the entire population of the transfectants was used for experiments. All cells were maintained in DMEM supplemented with 10% FBS, antibiotics and puromycin.
The Ras-transformed NIH3T3 cells were kindly provided by Dr Ari Elson. All cell lines were grown in DMEM supplemented with 10% FBS and antibiotics.
Western blot analysis Cells were washed with cold PBS, harvested and lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.2, 0.5% NP-40, 1% Triton X-100, 1% sodium deoxycholate). Samples containing 50 mg protein were resolved by 12% SDS-PAGE and subjected to immunoblot analysis as described previously (Gandre et al., 2002) . Anti-AzI and anti-ODC antibodies were raised in rabbits against bacterially expressed proteins ( Bercovich and Kahana, 2004) .
Semiquantitative RT-PCR Total cellular RNA was isolated from various NIH3T3-based cell lines using TRI Reagent (Ambion Inc., Austin, TX, USA), according to manufacturers instructions. Equal aliquots (1 mg) were reverse transcribed into cDNA with SuperScript II Reverse Transcriptase Kit (Invitrogent Corporation, Carlsbad, CA, USA), using oligo(dT) 12À18 primer. Equal amounts of cDNA were subsequently amplified by PCR, using ReadyMix PCR kit (BioLab Inc., Westlake, LA, USA). The gene-specific primers used were: mAzI (forward -TTGCAAATATAAAA CCCAAATGA, reverse -CATTTCAACAGGCCAAACTG), mODC (forward -AACGATAGCAGAG-CCATAGTGA, reverse -TCCGTTACTGGCAGCATACTT), mAz (forward -CCTGAGGGCAGTAAGGAC-AG, reverse -CATGTGG ACTAACCCAGGAGA), and mouse b-actin (forward -TT GCTGACAGGATGCAGAAG, reverse -AGCGCCAAA-A CAAAACAAAA).
Determination of growth rate Cells were plated in 12-well plates and grown in medium supplemented with 10% FBS, 0.5% FBS, or 10% FBS and 10 mM of the toxic polyamine analog CGC-11157. At the indicated times cells were trypsinized and counted using Bright Line Counting Chamber (Hausser Scientific, Horsham, PA, USA).
Growth in soft agar
Cells (1 Â 10 5 ) were mixed with medium containing 0.3% agar and were spread on top of a bottom agar layer (0.7% agar in growth medium). Fresh layer of medium containing 0.3% agar was added weekly on top of the previous layer. Colonies were photographed after 2 weeks.
Tumorigenicity assay
Control NIH3T3-E and NIH3T3-AzI were injected subcutaneously into flanks of nude BALB/cby-nu mice (3 Â 10 6 cells/ injection). Twenty animals were injected with control cells, and 23 animals with the AzI overexpressing cells.
siRNA assay
The previously described specific siRNA sequence targeting both mouse and human AzI (GAAGAAATACAAGGAA-GATGAG) (Choi et al., 2005) was inserted into the EcoRI and XhoI sites of pSUPER vector (Brummelkamp et al., 2002) . The resulting siAzI-pSuper vector was used to transiently transfect MCF7 cells, using jetPEIt reagent (Polyplus-transfection, SA), and the experiments were performed 24-48 h posttransfection.
ODC activity ODC activity assay was performed as previously described (Tobias and Kahana, 1993) . Aliquots of cellular extract containing 100 mg of protein were mixed with 100 ml ODC activity buffer (25 mM Tris-HCl pH 7.5, 2.5 mM DTT, 0.1 mM EDTA, 0.2 mM pyridoxal phosphate, 0.33 mM L-ornithine), containing 0.5 mCi L-[ 14 C] ornithine. Incubation was at 371C in a 96-well plate for 4 h. Liberated 14 CO 2 was trapped in a covering 3 mm filter paper impregnated with saturated solution of barium hydroxide. After the incubation the paper was washed with acetone, dried and exposed to a PhosphoImager screen. The results were quantified using Exbam program (Pixlock e.K).
Polyamine uptake assay
Uptake experiments were performed as previously described (Morgan, 1998) . Briefly, cells (2 Â 10 4 ) were seeded in 96-well plate, in 200 ml DMEM. After 24 h the cells were washed, and incubated at 371C for 15 min, in the presence of 50 ml of 0.5 or 5 mM [ 3 H] spermidine (36 Ci/mmol). Next, the cells were washed three times and protein content was determined. Finally, the cells were digested with formic acid (25 M), transferred into vials containing 3 ml UltimaGold LCS coctail (PerkinElmer Inc.) and radioactivity was determined using a liquid-scintillation counter.
Determination of cellular polyamine content
Polyamines were determined as previously described (Seiler, 1970; Gandre et al., 2002) . Cells were collected and resuspended in 500 ml of PBS and the material precipitating in 3% perchloric acid was removed by centrifugation. Dansyl-chloride (400 ml of 30 mg/ml solution) was mixed with a 200 ml aliquot of the supernatant; 20 mg of sodium carbonate was then added and the mixture was incubated in the dark for 12 h. Next, 100 ml of 100 mg/ml proline was added and the mixture was incubated for an additional 1 h. Dansylaed derivates were then extracted into 0.5 ml toluene. Aliquots of 50 ml were spotted on silica G-50 plates (Merck, KGaA, Germany) and the dansylated derivates were resolved using ethyl acetate/cyclohexane (2 : 3) as a solvent. Dansylated derivatives of known polyamines served as markers. The individual polyamines were visualized by UV illumination.
